Pharmacological management of hypertension in the elderly and frail populations

Expert Review of Clinical Pharmacology
Ashish CorreaWilbert S Aronow

Abstract

Cardiovascular disease is a leading cause of mortality in the elderly. Hypertension is an important modifiable risk factor that contributes to cardiovascular morbidity and mortality. The prevalence of hypertension is known to increase with age, and hypertension has been associated with an increase in risk for cardiovascular disease in the elderly. There is a wealth of evidence that supports aggressive control of blood pressure to lower cardiovascular risk in the general population. However, there are limited data to guide management of hypertension in the elderly and frail patient subgroups. These subgroups are inadequately treated due to lack of clarity regarding blood pressure thresholds, treatment targets, comorbidities, frailty, drug interactions from polypharmacy, and high cost of care. Areas covered: We review the current evidence behind the definition, goals, and treatments for hypertension in the elderly and frail and outline a strategy that can be used to guide antihypertensive pharmacotherapy in this population. Expert commentary: Lower blood pressure to < 130/80 mm Hg in elderly patients if tolerated and promote use of combination therapy if the blood pressure is > 20/10 mm Hg over the goal blood pressure. Antihypert...Continue Reading

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Oct 1, 1993·Hypertension·R D LangerT G Ganiats
Oct 1, 1996·Journal of Hypertension·L GongP Hamet
Jun 20, 1998·JAMA : the Journal of the American Medical Association·F H MesserliU Goldbourt
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
May 12, 2001·Journal of the American Geriatrics Society·S SatishJ S Goodwin
Jul 16, 2002·JAMA : the Journal of the American Medical Association·Dennis T KoHarlan M Krumholz
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Nov 10, 2004·The New England Journal of Medicine·Anne L TaylorUNKNOWN African-American Heart Failure Trial Investigators
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN CAMELOT Investigators
Feb 7, 2006·Journal of the American College of Cardiology·Carl J PepineUNKNOWN INVEST Investigators
May 11, 2006·Journal of Hypertension·Hisatomi ArimaUNKNOWN PROGRESS Collaborative Group
Jul 26, 2006·Hypertension·Frans H H LeenenUNKNOWN Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Sep 12, 2007·The American Journal of Cardiology·Giuseppe Mancia
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Jul 9, 2008·Nature Clinical Practice. Cardiovascular Medicine·Wilbert S Aronow
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Dec 17, 2008·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 14, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·UNKNOWN JATOS Study Group
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi

❮ Previous
Next ❯

Citations

Feb 25, 2019·Biological Trace Element Research·Jiwei LiuHongmei Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Cardiology in Review
Zainab SamadL Kristin Newby
The American Journal of Geriatric Cardiology
R W Schrier
Nature Reviews. Cardiology
Eduardo Pimenta, Suzanne Oparil
© 2022 Meta ULC. All rights reserved